Advertisement
Original article| Volume 42, 102126, July 2020

AQP4-IgG may cause muscle damage in patients with neuromyelitis optica spectrum disorder

  • Author Footnotes
    1 These authors contributed equally to this work and should be considered joint first authors.
    Ying Zhang
    Footnotes
    1 These authors contributed equally to this work and should be considered joint first authors.
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work and should be considered joint first authors.
    Hongxi Chen
    Footnotes
    1 These authors contributed equally to this work and should be considered joint first authors.
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Ziyan Shi
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Qin Du
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Yuhan Qiu
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Zhengyang Zhao
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Jiancheng Wang
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Chao Yan
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China

    Department of Neurology, Zigong Fourth People's Hospital, Zigong, Sichuan Province, China
    Search for articles by this author
  • Qin Zhang
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Mu Yang
    Affiliations
    Sichuan Cancer Hospital and Research Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Hongyu Zhou
    Correspondence
    Corresponding author: Department of Neurology, West China Hospital of Sichuan University, Guo Xuexiang #37, Chengdu 610041, China.
    Affiliations
    Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work and should be considered joint first authors.

      Highlights

      • AQP4-IgG-positive NMOSD patients had higher log sCK levels than the negative ones.
      • Male, serum AQP4-IgG and combined CTD were independent predictors of log sCK levels.
      • Muscle damage in NMOSD patients may be associated with AQP4-IgG.

      Abstract

      Background

      Muscle damage has been found in patients with neuromyelitis optica spectrum disorder (NMOSD), but whether this damage is related to aquaporin-4 immunoglobulin G antibodies (AQP4-IgG) is uncertain. The aim of this study was to investigate the relationship between AQP4-IgG and muscle damage.

      Methods

      From January 2009 to May 2019, we prospectively screened 1209 Chinese Han patients with acute transverse myelitis (ATM). Ultimately, we included 203 ATM patients in the cohort study and compared log serum creatine kinase (sCK) levels between positive and negative AQP4-IgG statuses.

      Results

      Among all ATM patients, the mean log sCK levels of AQP4-IgG-positive patients were higher than those of AQP4-IgG-negative patients (4.46 ± 0.10 vs. 4.16 ± 0.06, p < 0.001). In addition, among ATM patients diagnosed with NMOSD, the mean log sCK levels of AQP4-IgG-positive patients were higher than those of AQP4-IgG-negative patients (4.46 ± 0.10 vs. 4.05 ± 0.13, p = 0.025). The number of extremely high sCK values (sCK values > 300 IU/L) was significantly higher in ATM patients positive for AQP4-IgG than in those negative for AQP4-IgG (p = 0.020). Furthermore, multivariable linear regression model analysis showed that male sex (coefficient [95% CI] = 0.548 [0.286, 0.809], p < 0.001), serum AQP4-IgG (coefficient [95% CI] = 0.462 [0.237, 0.687], p < 0.001), and combined connective tissue disease (CTD) (coefficient [95% CI] = -0.686 [-1.145, -0.226], p = 0.004) were independent predictors of log sCK levels.

      Conclusions

      Our study suggests that muscle damage in NMOSD patients may be associated with AQP4-IgG.

      Keywords

      Abbreviations:

      NMOSD (neuromyelitis optica spectrum disorder), ATM (acute transverse myelitis), IATM (idiopathic acute myelitis), AQP4-IgG (aquaporin-4 immunoglobulin G antibodies), sCK (serum creatine kinase), CTD (connective tissue disease), CNS (central nervous system), AQP4 (Aquaporin-4), BBB (blood-brain barrier), TMCWG (Transverse Myelitis Consortium Working Group), MOG-IgG (myelin oligodendrocyte glycoprotein immunoglobulin G antibody), OCBs (oligoclonal bands), MS (multiple sclerosis), MOG-EM (MOG-IgG-associated encephalomyelitis), SVMs (spinal vascular malformations), SCIs (spinal cord injuries), PNS (paraneoplastic syndrome), CBA (cell-based assay), MRI (magnetic resonance imaging), ANA (serum antinuclear antibody), anti-SSA (serum anti-Sjögren syndrome A), anti-SSB (serum anti-Sjögren syndrome B), eGFR (estimated glomerular filtration rate), CIs (confidence intervals), SLE (systemic lupus erythaematosus), SS (Sjögren syndrome)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Basco D.
        • Nicchia G.P.
        • D’Alessandro A.
        • Zolla L.
        • Svelto M.
        • Frigeri A.
        Absence of aquaporin-4 in skeletal muscle alters proteins involved in bioenergetic pathways and calcium handling.
        PLoS ONE. 2011; 6: e19225
        • Chen H.X.
        • Zhang Q.
        • Lian Z.Y.
        • Liu J.
        • Shi Z.Y.
        • Miao X.H.
        • Feng H.R.
        • Du Q.
        • Xie J.L.
        • Yao S.L.
        • Zhou H.Y.
        Muscle damage in patients with neuromyelitis optica spectrum disorder.
        Neurol. Neuroimmunol. Neuroinflamm. 2017; 4: e400
        • Cosgrove J.
        • Alli S.
        • Ramadan H.
        • Ford H.L.
        Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
        Mult. Scler. 2014; 20: 120-122
        • Di Filippo M.
        • Franciotta D.
        • Massa R.
        • Di Gregorio M.
        • Zardini E.
        • Gastaldi M.
        • Terracciano C.
        • Rastelli E.
        • Gaetani L.
        • Iannone A.
        • Menduno P.
        • Floridi P.
        • Sarchielli P.
        • Calabresi P.
        Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
        Neurology. 2012; 79: 1182-1184
        • Frigeri A.
        • Nicchia G.P.
        • Balena R.
        • Nico B.
        • Svelto M.
        Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
        FASEB J. 2004; 18: 905-907
        • Group T.M.C.W.
        Proposed diagnostic criteria and nosology of acute transverse myelitis.
        Neurology. 2002; 59: 499-505
        • Guo Y.
        • Lennon V.A.
        • Popescu B.F.
        • Grouse C.K.
        • Topel J.
        • Milone M.
        • Lassmann H.
        • Parisi J.E.
        • Pittock S.J.
        • Stefoski D.
        • Balabanov R.
        • Lucchinetti C.F.
        Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum.
        JAMA Neurol. 2014; 71: 1025-1029
        • He D.
        • Li Y.
        • Dai Q.
        • Zhang Y.
        • Xu Z.
        • Li Y.
        • Cai G.
        • Chu L.
        Myopathy associated with neuromyelitis optica spectrum disorders.
        Int. J. Neurosci. 2016; 126: 863-866
        • He D.
        • Zhang A.
        • Li Y.
        • Cai G.
        • Li Y.
        • Guo S.
        Autoimmune aquaporin-4 induced damage beyond the central nervous system.
        Mult. Scler. Relat. Disord. 2017; 18: 41-46
        • Iorio R.
        • Pittock S.J.
        Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies.
        Clin. Exp. Neuroimmunol. 2014; 5: 175-187
        • Iyer A.
        • Rathnasabapathi D.
        • Elsone L.
        • Mutch K.
        • Terlizzo M.
        • Footitt D.
        • Jacob A.
        Transverse myelitis associated with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformis.
        JAMA Neurol. 2014; 71: 630-633
        • Mader S.
        • Lutterotti A.
        • Di Pauli F.
        • Kuenz B.
        • Schanda K.
        • Aboul-Enein F.
        • Khalil M.
        • Storch M.K.
        • Jarius S.
        • Kristoferitsch W.
        Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
        PLoS ONE. 2010; 5
        • Malik R.
        • Lewis A.
        • Cree B.A.
        • Ratelade J.
        • Rossi A.
        • Verkman A.S.
        • Bollen A.W.
        • Ralph J.W.
        Transient hyperckemia in the setting of neuromyelitis optica (NMO).
        Muscle Nerve. 2014; 50: 859-862
        • Maria P.
        • Naoto K.
        • Maja K.
        • Jan B.
        • Rui M.
        • Marie-Therese F.
        • Joana M.-.S.
        • Simone M.
        • W E.J.
        • Tatsuro M.
        • Kazuo F.
        • Hartmut W.
        • Markus R.
        • Hans L.
        • Monika B.
        T cell-activation in neuromyelitis optica lesions plays a role in their formation.
        Acta Neuropathol. Commun. 2013; 1
        • Matiello M.
        • Schaefer-Klein J.
        • Sun D.
        • Weinshenker B.G.
        Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
        JAMA Neurol. 2013; 70: 1118-1125
        • Michel V.-.D.
        • Ulf S.-.T.
        • A N.P.
        • M S.R.
        • C C.B.A.
        • S Z.S.
        Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
        Ann. Neurol. 2012; 72
        • Mitsdoerffer M.
        • Kuchroo V.
        • Korn T.
        Immunology of neuromyelitis optica: a T cell-B cell collaboration.
        Ann. N. Y. Acad. Sci. 2013; 1283: 57-66
        • Neal R.C.
        • Ferdinand K.C.
        • Ycas J.
        • Miller E.
        Relationship of ethnic origin, gender, and age to blood creatine kinase levels.
        Am. J. Med. 2009; 122: 73-78
        • Pittock S.J.
        • Lucchinetti C.F.
        Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
        Ann. N. Y. Acad. Sci. 2016; 1366: 20-39
        • Sanmarti R.
        • Collado A.
        • Gratacos J.
        • Herrera B.E.
        • Font J.
        • Canete J.D.
        • Orellana C.
        • Munoz-Gomez J.
        Reduced serum creatine kinase activity in inflammatory rheumatic diseases.
        J. Rheumatol. 1996; 23: 310-312
        • Shang K.
        • Qin C.
        • Bu B.T.
        • Tian D.S.
        Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder subsequent to rhabdomyolysis: a case report and literature review.
        Int. J. Neurosci. 2019; 129: 930-932
        • Shouman K.
        • Prieto P.G.
        • Stino A.M.
        • Lisak R.P.
        Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder.
        J. Neuroimmunol. 2019; 330: 87-89
        • Suzuki N.
        • Takahashi T.
        • Aoki M.
        • Misu T.
        • Konohana S.
        • Okumura T.
        • Takahashi H.
        • Kameya S.
        • Yamaki K.
        • Kumagai T.
        • Fujihara K.
        • Itoyama Y.
        Neuromyelitis optica preceded by hyperCKemia episode.
        Neurology. 2010; 74: 1543-1545
        • Waters P.J.
        • Pittock S.J.
        • Bennett J.L.
        • Jarius S.
        • Weinshenker B.G.
        • Wingerchuk D.M.
        Evaluation of aquaporin‐4 antibody assays.
        Clin. Exp. Neuroimmunol. 2014; 5: 290-303
        • Wei N.
        • Pavlidis N.
        • Tsokos G.
        • Elin R.J.
        • Plotz P.H.
        Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases.
        JAMA. 1981; 246: 1921-1923
        • Wingerchuk D.M.
        • Banwell B.
        • Bennett J.L.
        • Cabre P.
        • Carroll W.
        • Chitnis T.
        • de Seze J.
        • Fujihara K.
        • Greenberg B.
        • Jacob A.
        • Jarius S.
        • Lana-Peixoto M.
        • Levy M.
        • Simon J.H.
        • Tenembaum S.
        • Traboulsee A.L.
        • Waters P.
        • Wellik K.E.
        • Weinshenker B.G.
        International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
        Neurology. 2015; 85: 177-189
        • Yao X.
        • Verkman A.S.
        Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
        Acta Neuropathol. Commun. 2017; 5: 57
        • Yokoyama N.
        • Niino M.
        • Takahashi T.
        • Matsushima M.
        • Maruo Y.
        Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.
        Eur. J. Neurol. 2012; 19: e143